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Abstract
Background/Aims: Different components of the tumor microenvironment can be either 
tumor-promoting or tumor-suppressive agents depending on factors which are not fully 
understood. Fibulins are components of the extracellular matrix from different tissues and 
constitute a clear example of this dual function. In fact, fibulins may either support tumor 
growth or abolish progression of malignant cells depending on the crosstalk between tumor 
cells and their surrounding stroma through mechanisms that remain to be elucidated. Among 
all fibulins, fibulin-5 contains a particular structural hallmark which consists in the presence 
of a RGD motif within its architecture. Previous reports have highlighted the importance of 
the interaction of this motif with integrins, and not only in normal functions but also in a 
tumor context. Methods: Site-Directed Mutagenesis technique was employed to introduce 
the change RGD to RGE (RGD-to-RGE) within Fbln5 cDNA sequence. Cell proliferation was 
measured using the MTT assay or by counting Ki-67 positive cell nuclei.  Cell adhesion was 
analysed using culture plates coated with different extracellular matrix components. Cell 
invasion was evaluated using 24-well Matrigel-coated invasion chambers, and mammosphere 
formation was monitored using ultralow attachment culture plates. BALB/c mice were 
employed to induce subcutaneous tumors. Results: The RGD-to-RGE change alters the 
capacity of breast cancer cells to adhere to different extracellular matrix proteins as well as 
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to αvβ3 and α5β1 integrins, and promotes protumor effects using different cell-based assays. 
Moreover, 4T1 cells, a mouse breast cancer cell line model, shows an increased capacity to 
generate tumors when exogenously expresses fibulin-5 with a RGD-to-RGE change, and such 
capacity is similar to that shown for 4T1 cells with an interfered Fbln5 gene. Conclusion: These 
data highlight the importance of the RGD motif of fibulin-5 to induce antitumor effects and 
provide new insights into the involvement of fibulins in tumor processes.
IntroductionAcellular components of the cell microenvironment form a structural framework to give support to cells and tissues. However, this intricate network of complex molecules and sequestered growth factors, known as extracellular matrix (ECM), not only forms an 
architectural scaffold for cells but also regulates cellular activities that influence processes 
such as differentiation, proliferation or migration [1]. Functional significance of ECM is illustrated by the number of anomalies associated to its components which lead to the development of pathological conditions, including cancer [2]. In fact, ECM is highly disorganized in tumor processes and can contribute to promote growth and dissemination of malignant cells [3]. However, different ECM components can act as protumor or antitumor 
factors through mechanisms not fully understood and fibulins exemplify this dual function 
in tumorigenesis [4, 5]. Originally identified as components of elastic fibers, fibulins play key roles in a wide range of biological processes related to tissue homeostasis and remodeling; 
and their biological importance is highlighted through the severe deficiencies shown by the 
mouse models lacking a particular fibulin gene [6]. In relation to cancer, a growing number 
of studies have revealed that effects of fibulins are complex and variable dependent on different factors [5].Fibulin-5, also known as EVEC and DANCE, constitutes a clear example of the importance 
of fibulins in those processes. This 66-kDa glycosylated protein contains different motifs within its structure involved in the interaction with other ECM proteins [7, 8]. Generation 
of the mouse deficient in fibulin-5 coding gene, Fbln5, revealed its importance in biological functions [9, 10]. Although Fbln5-deficient mice survive to adulthood, they develop severe 
abnormalities derived from elastic fiber defects, including genital prolapse, emphysematous lungs and cutis laxa. Regarding to tumor processes, both protumor and antitumor roles have 
been associated to fibulin-5, which seem to be context-dependent [11]. For instance, levels of FBLN5 messenger RNA were found downregulated in a variety of human tumor samples 
[11]; and fibulin-5 inhibits invasion of bladder [12] and lung [13, 14] cancer cells through 
different mechanisms. These findings suggest a tumor-suppression function for fibulin-5. In 
stark contrast, fibulin-5 mediates lung metastasis in a rat model of renal cell carcinoma [15] 
and also induces nasopharyngeal carcinoma cell metastasis [16]. Furthermore, fibulin-5 
is associated to EMT in breast [17] and cervical cancer cells [18], via TGF-β and Nogo-B dependent-mechanisms respectively.
We have previously reported the tumor-suppressive effects of the exogenous fibulin-5 
expression in breast cancer cells [19]. Taking into account that fibulin-5 is the only member 
of the fibulin family containing a RGD integrin binding motif [7], and the importance of this motif not only in normal physiological conditions but also in tumorigenesis [20], we wanted 
to investigate whether the RGD-to-RGE change could affect behavior of the murine 4T1 and the human MDA-MB-231 breast cancer cell lines. Our data show a potent protumor activity 
of cells expressing a recombinant fibulin-5 containing this change, and provide new insights 
into the significance of fibulin-5 in tumor processes.
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Materials and Methods
Cells lines and cell culture conditions
Human MDA-MB-231 and murine 4T1 breast cancer cell lines were kindly provided by Dr. Carlos López-Otín and Dra. Ana Gutiérrez-Fernández. (University of Oviedo, Spain). Cells were routinely 
maintained in Dulbecco’s Modified Eagle’s medium (DMEM) containing 10 %  fetal bovine serum, 50 μg/mL 
streptomycin and 100 U/mL penicillin (Life Technologies). For transfection experiments, vector containing 
the human full-length cDNA for fibulin-5 was kindly provided by Dr William P. Schiemann (Case Western Reserve University, Cleveland, USA). RNA interference kit for knocking down Fbln5 gene was purchased from Origene. Vectors were transfected into cells at 75% confluence using Lipofectamine reagent (Life 
Technologies) as recommended by the manufacturer. Cells transfected with an empty vector (control) or 
stably expressing FBLN5 (Fibulin5-WT) were selected with 500 μg/mL G418 (Sigma-Aldrich); and cells 
with interfered FBLN5 gene (Fibulin-5KD cells) with 0.5 µg/mL puromycin.
Mutagenesis
The QuikChange II XL Site-Directed Mutagenesis Kit (Agilent) was employed to introduce the change RGD to RGE (RGD-RGE) within the Fbln5 sequence, following the manufacturer´s instructions. Primers 
designed for mutagenesis were: FBLN5MUT-Fw 5′-GCCTGCCGAGGAGAGATGATGTGTGTTAAC-3′ and 
FBLN5MUT-Rv 5′- GTTAACACACATCATCTCTCCTCGGCAGGC -3′, Vector containing the full-length cDNA for 
FBLN5 was employed as template. PCR conditions were as follows: 95 °C, 1 min (1 cycle); 95 °C, 50 s, 66°, 
50 s and 68° 12 min (18 cycles); and 68 °C, 7 min (1 cycle). PCR products were visualized in a 1.0% agarose 
gel and DNA sequence was verified before experimental use. Breast cancer cells expressing mutant FBLN5 
(Fibulin5-RGE) were selected with 500 μg/mL G418 (Sigma-Aldrich) as described above.
Western-blot and immunocytochemical analysis
Cell extracts were resolved by 8 or 10 polyacrylamide gel electrophoresis, transferred to a PVDF 
membrane (Millipore) and subsequently probed with the indicated antibodies. The primary antibodies 
were anti-fibulin-5 antibody from Origene or Santa Cruz Biotechnology; anti-β-actin and anti-α-SMA 
antibodies from Sigma-Aldrich; anti-Ki-67, anti-E-cadherin, anti-N-cadherin and anti-vimentin from Santa 
Cruz Biotechnology. Immunoreactive proteins were visualized using HRP-peroxidase labeled anti-rabbit or 
anti-mouse secondary antibody and the ECL detection system (Pierce). For immunocytochemical analysis, 
4T1 cells were fixed with 4% paraformaldehyde and then were blocked with 10% fetal bovine serum. To 
detect Ki-67, fixed cells were incubated overnight with the H-300 antibody from Santa Cruz Biotechnologies, 
followed by 1 h incubation with a secondary Alexa 546-conjugated antibody (Life Technologies). DAPI was 
added at 100 ng/mL to visualize DNA in cell nucleus. Images were obtained using a fluorescence microscope (Axiovert).
Cell proliferation assay
Cell proliferation was measured using the CellTiter 96 Non-radiactive Cell Proliferation Assay kit 
(Promega). MBA-MB-231 and 4T1 cells (5×103/well) were seeded in 96-well plates and six replicates were 
performed per condition. Cell proliferation rates were determined on four (4T1) or five (MDA-MB-231) 
consecutive days using an automated microtiter plate reader Power Wave WS (BioTek). Additionally, cell 
proliferation was also estimated as an average of Ki-67-positive nuclei in relation to the total number of 
nuclei per microscopic field as previously reported [19]. To this end, 5×103 stably transfected cells were plated in µ-Dish 35 mm from Ibidi.
Cell adhesion assay
The adhesion capacity of the breast cancer lines 4T1 and MDA-MB-231 was analysed using 24-cell 
culture plates (VWR) coated with fibronectin, laminin, type IV collagen (Sigma-Aldrich) and αvβ3 and α5β1 
integrins (R&D Systems). Uncoated wells were employed as a control. For all conditions 3×105 cells/mL 
were employed, with the exception of MDA-MB -231 in the wells coated with integrin αvβ3 which were used at 1x104 cells/mL. Cells were seeded and allowed to adhere at 37 ºC and 5% CO2 for 30 min. Then, 
non-adhered cells were removed by washing three times with PBS and remaining cells were fixed with 
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4% paraformaldehyde and stained with cell stain solution. All data are the mean of three independent experiments.
Invasion assay
In vitro invasion potential was evaluated using 24-well Matrigel-coated invasion chambers with a 8 
µm pore size (BD Biosciences). To this end, 5×104 4T1 or MDA-MB-231 cells were allowed to migrate for 
24 h using 10% fetal bovine serum as a chemoattractant. At least three independent experiments were made for each condition. Non-invading cells on the upper surface were removed from the chambers using 
a cotton swab and cells that reached the lower surface were fixed with 4% paraformaldehyde and stained 
with crystal violet. Cells were counted in three randomly selected microscopic fields.
Mammospheres culture
To evaluate mammosphere formation capacity of breast tumor cells, 4×104 4T1 cells were plated in 
6-well ultralow attachments plates (Corning Costar) and grown in MammoCult Basal Medium (Stemcell 
Technologies) supplemented with 10% MammoCult proliferation supplement, 4 μg/mL heparin and 
0.5 μg/mL hydrocortisone. After 7 days, mammospheres were collected and enzymatically dissociated. 
Individual dissociated cells were cultured in 96-well ultralow attachment plates at a density of 20 cells/well. Mammosphere formation was monitored microscopically daily to ensure they derived from single cells and 
not from aggregates. Number of mammospheres was quantified and graphically represented after 7 days.
Animals and subcutaneous tumors
Six to eight-week-old male BALB/c mice (Charles River Laboratories) were used for in vivo studies. To 
induce subcutaneous tumors, four groups of five mice were injected at one flank with 1 x 105 cells of 4T1 
Fibulin5-KD, 4T1 Fibulin5-RGE cells and 4T1 cells in 100 µL PBS respectively. Tumor growth was monitored weekly and was measured with a calliper, and tumour volume was determined using the formula: V=0.4 
×A×B2, where A is the largest dimension of the tumour and B is the smallest dimension.
Statistical analysis
Data were analysed using GraphPad Prism 5.0 Software and represented as mean ± SD, or mean± SE 
when indicated. Significant differences were determined with the Student t-test for parametric data and 
the Mann-Whitney test for non-parametric data. P-values <0.05 were considered statistically significant 
(*P<0.05, **P<0.01, ***P<0.005).
Results
Fibulin-5RGE induces morphological changes in the 4T1 murine breast cancer cell line
Murine cell line 4T1 is an experimental model for mammary human cancer [21]. To 
examine the influence of the fibulin-5 RGD motif in the behavior of 4T1 cells, we carried out site-directed mutagenesis to introduce the Asp to Glu change (RGD-to-RGE) at position 
56 of the amino acid sequence of the human fibulin-5 (Fig. 1A). Following transfection, we 
selected clones containing the RGD-to-RGE change (4T1 Fibulin-5RGE cells). As a control, 
we used same cell line that exogenously expressed wild-type fibulin-5 (4T1 Fibulin-5WT 
cells). In addition, we carried out RNA interference on FBLN5 gene (4T1 Fibulin-5KD cells) 
for comparative purposes. Expression level of fibulin-5, Fibulin-5RGE and fibulin-5KD in 
selected clones was analyzed by Western-blot. 4T1 cells transfected with an empty vector 
were employed as control (Fig. 1B). Cell morphology was further examined with the finding 
that both 4T1 Fibulin-5RGE and 4T1 Fibulin-5KD cells shifted the epithelial-like phenotype 
of this cell line towards a mesenchymal-like phenotype (Fig. 1C). However, 4T1 Fibulin-5WT 
cells did not undergo any apparent morphological alteration. To investigate the mechanisms underlying those morphological changes, we explored the expression levels of E-cadherin, 
N-cadherin and vimentin. Both 4T1 Fibulin-5RGE and 4T1 Fibulin-5KD cells showed a drastic decrease in E-cadherin expression with respect to control cells (Fig. 1D). By contrast, 
expression levels of N-cadherin and vimentin were increased in Fibulin-5RGE and 4T1 
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Fibulin-5KD cells, but decreased in Fibulin-5WT cells. Overall, these data are compatible 
with an alteration of the epithetial-to-mesenchymal transtition (EMT) process due to the 
RGD-to-RGE change in fibulin-5 when expressed in 4T1 cells.
Fibulin-5RGE increases proliferation of 4T1 cells
We have previously shown that presence of exogenous fibulin-5 reduces proliferation of 
human breast cancer cells which do not express endogenous fibulin-5 [19]. Now, we wanted 
to evaluate whether the proliferation of the murine 4T1 cell line, which endogenously 
Fig. 1. Effects of the RGD-to-RGE in fibulin-5 in 4T1 cells. A. Sequencing electropherograms showing the 
substitution of C to G in the cDNA (indicated with an asterisk), resulting in a change D56E in the amino 
acid sequence of fibulin-5. B. Western-blot showing the expression of fibulin-5 in 4T1 cells. Control cells transfected with an empty vector are indicated as C, interfered cells as Fibulin-5KD, transfected with the 
full-cDNA for fibulin-5 as Fibulin-5WT, and cells transfected with cDNA for fibulin-5 containing the RGD-
to-RGE are indicated as Fibulin-5 RGE. Molecular weight is indicated on the right. β-actin was employed as 
loading control. Intervening irrelevant lanes are not shown. C. Morphological changes in fibulin-5 (Fibulin-
5KD) interfered 4T1 cells and in 4T1 cells containing the RGD-to-RGE change in fibulin-5. Bar, 100 µm. 
D. Western-blot showing the expression of the EMT markers E-cadherin, N-cadherin and vimentin in the 
indicated cells. Molecular weight markers are indicated on the right and β-actin was employed as loading control.
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expresses fibulin-5, can be affected by the exogenous expression of fibulin-5 or fibulin5-RGE. 
To this end we performed two different approaches. First we examined expression of the 
nuclear marker Ki-67 (Fig. 2A). Number of Ki-67 positive nuclei does not differ substantially 
between control (an average of 27% of cells showed Ki-67-positive nuclei staining) and 4T1 
Fibulin-5WT cells (23%). However, 4T1 Fibulin-5RGE cells showed considerable increased 
in the number of Ki-67 positive nuclei (78%) respecting control and 4T1 Fibulin-5WT cells. Interestingly, 4T1 Fibulin-5KD cells also increased number of positive Ki-67 nuclei 
(65%). Differences in Ki-67 expression could be also appreciated by Western-blot (Fig. 2A). 
Fig. 2. RGD-to-RGE change in fibulin-5 affects proliferation of 4T1 cells. A. Expression of the proliferative 
nuclear marker Ki-67 was examined by immunocytochemistry. Top, representative images of Ki-67 staining 
(in red) in the indicated 4T1 cells. Cell nuclei are shown in blue; bar, 10 µm.  Bottom left, quantification of 
Ki-67 positive nuclei. Bottom right, Western-blot analysis showing Ki-67 expression in the indicated cells. 
Molecular weight markers are indicated on the right and β-actin was employed as loading control. B. Cell 
proliferation of the 4T1 cells employed in this work measured by MTT assay.
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Second approach consisted 
of a MTT assay (Fig. 2B). 
Again 4T1 Fibulin-5RGE 
and 4T1 Fibulin-5KD cells showed an increased level of proliferation respect to 
control and 4T1 Fibulin-
5WT cells. These results 
illustrate the influence 
of an intact fibulin-5 to control breast cancer cell proliferation.
Fibulin-5RGE increases 
the capacity of 4T1 cells 
to form mammospheres
4T1 cells shows a strong capacity to form 
mammopheres [22].  To examine whether the exogenous expression of Fibulin-5RGE could affect this capacity, mammosphere-forming units (MFU) were counted for the different conditions assayed. As can be seen 
in Fig. 3, 4T1 Fibulin-5RGE cells showed the highest capacity to form mammospheres in two consecutive passages. 
Thus, in the first passage 
4T1 Fibulin-5RGE cells showed a 3.2-fold increase in their ability to form mammospheres with respect to control cells; and 2-fold increase in 
the second passage. This ability is also increased in 
4T1 Fibulin-5KD cells, but 
only in the first passage (2-fold increase). We also noticed that size of mammospheres did not 
show significant changes among the conditions assayed. However, sharp morphological changes can be observed in 
mammospheres derived from 4T1 Fibulin-5RGE cells and 4T1 Fibulin-5KD cells (Fig. 3). 
These changes can be related with the decrease in N-cadherin expression [23], and it could indicate that the anchorage-independent growth may be facilitated in breast cancer cells 
harboring the RGD-to-RGE change in fibulin-5.
Fig. 3. Mammosphere-formation assay using 4T1 cells. Quantification (mammosphere-forming unit, MFU, calculated as a percentage of mammospheres formed from the number of cells seeded). Bars, standard error. Representative images of mammospheres derived from the cells employed in this work in two consecutive passages are also 
shown. Morphological changes are mainly observed in 4T1 Fibulin-
5KD and 4T1 Fibulin-5RGE cells. Bar, 50 µm.
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Influence of the RGD-to-RGE change in fibulin-5 in the adhesion and invasion properties 
of 4T1 cells
To explore whether the RGD-to-RGE change in fibulin-5 may alter adhesion properties 
of 4T1 cells, we analyzed the capacity of the cells to bind to the ECM components fibronectin, 
laminin and type IV collagen. Results indicated that 4T1 Fibulin-5WT cells showed the highest capacity to bind to culture plates coated with these ECM components but also the 
binding to standard culture plates (Fig. 4A). In fact, above 180 cells per field were counted 
in the cases of binding of 4T1 Fibulin-5WT cells to fibronectin and type IV collagen, and it is 
noteworthy that in the case of fibronectin the number of attached cells was closed to 250 per 
field. On the contrary, number of attached 4T1 Fibulin-5KD and 4T1 Fibulin-5RGE cells was 
between 50 and 75 cells per field in all conditions assayed, including standard culture plates.
We also wanted to know the capacity of 4T1 cells to bind to culture plates coated with 
αvβ3 and α5β1 integrins (Fig. 4B). Again 4T1 Fibulin-5WT cells showed the highest capacity 
of attachment to both integrins (58 in the case of αvβ3 and and 48 in the case of α5β1 cells per 
field respectively), followed by control cells (42 and 36 cells per field). By contrast, neither 
4T1 Fibulin-5KD (11 and 19 cells per field) nor 4T1 Fibulin-5RGE (14 and 22 cells per field) 
cells showed a strong capacity to bind to the integrins αvβ3 or α5β1.
To examine the influence of the RGD-to-RGE change in fibulin-5 on the invasive capacity 
of 4T1 cells, we employed transwell inserts coated with Matrigel (Fig. 4C).  Both 4T1 Fibulin-
5KD cells (99 cells per field) and 4T1 Fibulin-5RGE cells (79 cells per field) showed an 
increase in their invasive properties as compared to 4T1 control cells (52 cells per field). 
In this assay, 4T1 Fibulin-5WT cells showed the lowest capacity to invade (28 cells per 
field). These data strongly suggest the influence of fibulin-5 in both cell attachment and cell invasion processes.
RGD-to-RGE change in fibulin-5 potentiates capacity of 4T1 cell to form tumors
The effect of the RGD-to-RGE change in fibulin-5 was examined in vivo through the 
subcutaneous injection of 4T1 Fibulin-5RGE cells in the flank of five male BALB/c mice. 4T1 
Fibulin-5, 4T1 Fibulin-5KD cells were employed for comparative analysis. Five mice were 
injected with 4T1 cells transfected with an empty vector as control purposes. Volumes of 
subcutaneous tumors formed were measured for six weeks (Fig. 5A). Tumors derived from 
4T1 Fibulin-5KD cells, but especially from 4T1 Fibulin-5RGE cells, showed a considerable larger volumes than those derived for control cells and tumors were macroscopically visible 
at three weeks. These results reinforce the tumor-protective effect of fibulin-5, but also highlight the involvement of its RGD domain to induce these effects.  In addition, we have 
also verified levels of fibulin-5 expression in tumors derived from Fibulin-5KD 4T1, Fibulin-
5RGE and control 4T1 cells (Fig. 5B).
RGD-to-RGE change in fibulin-5 alters behavior of MDA-MB-231 cellsNext, we wanted to know whether the results described above could be reproduced in a 
breast cancer cell which does not express fibulin-5 endogenously. To this end we employed 
the MDA-MB-231 cell line due to the expression level of fibulin-5 is undetectable by Western-
blot [19]. Following selection of cells expressing fibulin-5RGE (MDA-MB-231 Fibulin-
5RGE) and wild-type fibulin-5 (MDA-MB-231 Fibulin-5WT) (Fig. 6A), we first examined 
the expression of the EMT markers E-cadherin, N-cadherin and vimentin. Main findings consisted of an increase of E-cadherin expression level but a decrease of N-cadherin and 
vimentin expression levels in MDA-MB-231 Fibulin-5WT cells with respect to both MDA-
MB-231 Fibulin-5RGE cells and MDA-MB-231 control cells. Then, we evaluated the ability of 
the MDA-MB-231 to adhere to the ECM components fibronectin, laminin and type IV collagen. 
Results revealed that MDA-MB-231 Fibulin-5WT cells showed a high capacity to bind to 
fibronectin (144 cells per field), laminin (114 cells per field) and type IV collagen (113 cells 
per field), as compared with Fibulin-5RGE cells (15 to laminin and 19 to type IV collagen cells 
per field respectively) and control cells (23 to laminin and 15 to type IV collagen, Fig. 6B). In 
addition, we also examined the binding of those cells to wells coated with αvβ3 integrin. MDA-
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Fig. 4. RGD-to-RGE change in fibulin-5 alters the adhesion profile and the invasive ability of 4T1 cells. 
A. Left, representative images showing attachment of the indicated 4T1 cells to the ECM components 
fibronectin, laminin and type IV collagen. Adhesion to standard culture plates was also examined. Bar, 10 µm. Right, graphical representation of the number of attached cells. Exogenous expression of an intact 
fibulin-5 (Fibulin-5WT) increases the number of attached 4T1 cells in all assayed conditions. B. Ability of 
the 4T1 cells used in this work to bind to ααvβ3 integrin was also examined. Top, representative images 
of the indicated 4T1 cells attached to the αvβ3 integrin. Bar, 10 µm. Bottom, graphical representation of 
the number of attached cells to the αvβ3 and α5β1 integrins as indicated. Exogenous expression of an intact 
fibulin-5 (Fibulin-5WT) also increases adhesion of 4T1 cells (color code as in C) to the αvβ3 integrin. C. Top, 
representative pictures showing invasive 4T1 cells as indicated using Matrigel-coated invasion chambers. 
Bar, 10 µm. Bottom, quantification of the number of invasive cells.
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MB-231 Fibulin-5WT also increased their capacity of binding to this integrin (18 cells per 
field) as compared to both control (~3 cells per field) and MDA-MB-231 Fibulin-5RGE cells 
(~4 cells per field, Fig. 6C). Other results supporting the effect of the RGD-to-RGE change in MDA-MB-231 cells are indicated in Supplementary Fig. 1 and Supplementary Fig. 2 (for all 
supplemental material see www.cellphysiolbiochem.com). Thus, we performed an invasion 
assay to examine whether the differences in binding could influence invasive capacity of this cell line. Invasion ability of MDA-MB-231 cells was considerable reduced when expressing 
exogenous fibulin-5 (MDA-MB-231 Fibulin-5WT, 60 cells per field, Supplementary Fig. 1), as 
compared to invasion capacities of control (140 cells per field) and MDA-MB-231 Fibulin-
5RGE cells (188 cells per field). We also wanted to examine if Fibulin-5RGE induces similar 
effects on MDA-MB-231 cells proliferation than those described above for 4T1 cells. A MTT 
analysis revealed that fibulin-5 does not alter capacity of MDA-MD-231 cells to proliferate, 
contrary to what was observed for MDA-MB-231 Fibulin-5WT cells (Supplementary Fig. 
2). Taken together, these results strongly suggest that changes in the RGD motif of fibulin-5 may induce changes in breast cancer cells that ultimately lead to increase their protumor properties.
Fig. 5. RGD-to-RGE change in fibulin-5 increases the capacity of 4T1 cells to form subcutaneous tumors. 
Top, graphical representation of the tumor volumes formed by the indicated 4T1 cells when injected in the 
flank of BALB/c mice. Tumor volumes were measured for six weeks. Bottom, western-blot analysis of the 
fibulin-5 expression in three tumors formed by 4T1 Fibulin-5KD cells, four 4T1 Fibulin-5RGE cells and one 
control cells. Molecular weight marker is indicated on the right and β-actin was employed as loading control.
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Fig. 6. RGD-to-RGE change in fibulin-5 modifies behavior of MD-MB-231 cells. A. Western-blot showing 
the expression of the EMT markers E-cadherin, N-cadherin and vimentin in control MDA-MB-231 cells (C), 
MDA-MB-231 cells tranfected with the full-length cDNA for fibulin-5 (Fibulin-5WT), or transfected with the 
cDNA carrying the mutation to produce fibulin-5 containing the D56E change within its RGD motif (Fibulin-
5RGE). Molecular weight markers are indicated on the right and β-actin was employed as loading control. B. 
Top, representative images showing attachment of the indicated MDA-MB-231 cells to the ECM components 
fibronectin, laminin and type IV collagen. Adhesion to standard culture plates was also examined. Bar, 10 µm. Bottom, graphical representation of the number of attached cells. C.  Ability of the MDA-MB-231 cells 
used in this work to bind to the αv β 3 integrin was also examined. Top, representative images of the indicated 
MDA-MB-231 cells attached to the αv β 3 integrin. Bar, 10 µm. Bottom, graphical representation of the number of attached cells as indicated.
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DiscussionFibulin-5 is a structurally complex extracellular protein. Within its N-terminal region, 
six calcium-binding epithelial growth factor-like (cbEGF-like) domains can be identified and, 
in turn, a RGD motif is located in the first cbEGF-like domain [7]. It has been largely proven the function of the RGD motif in cell adhesion as well as its potential application in tumor 
therapy [24]. In the case of fibulin-5, it is known that its RGD motif mediates cell binding 
through the interaction with different integrins including αvβ3, αvβ5, α5β1 or α4β1 [9, 25]. For 
instance, fibulin-5 RGD motif can influence the attachment and spreading of primary aortic 
smooth muscle cells through β1 integrins. However, the  interaction between fibulin-5 RGD 
motif and β1 integrins failed to activate integrin-mediated signaling pathways, suggesting 
that fibulin-5 may act as a blocking factor [25].
In a tumor context, it has been shown that loss of interaction between fibulin-5 and 
β1 integrins hinders tumor growth by increasing the level of reactive oxygen species, affecting the angiogenesis process [20]. However, different reports have highlighted the 
tumor suppressor functions of fibulin-5 in bladder or lung cancers [5, 12, 13]. We have 
also previously shown that the exogenous expression of fibulin-5 also confers antitumor properties to breast cancer cell lines [19]. In this work we wanted to explore whether the 
RGD motif could affect the antitumor role of fibulin-5 in breast cancer cells. To this end we 
exogenously expressed fibulin-5 containing the RGD-to-RGE change in the murine 4T1 and the human MDA-MB-231 breast cancer cell lines. Different cell-based assays have revealed 
that the RGD-to-RGE change drastically abolishes the antitumor effect that an intact fibulin-5 displays, and similar results were obtained when we performed knock-down of the FBLN5 gene. Overall these data suggest that the RGD-to-RGE change induce effects comparable to those derived from a loss of function of the FBLN5 gene. In line with these results, a previous 
report has shown that fibulin-5 promotes adhesion to fibronectin and reduces invasion of 
hepatocellular carcinoma cells by an integrin-dependent mechanism [26]. However, these 
effects were not observed when the RGD motif of fibulin-5 was changed to RGE [26]. We also 
wanted to examine whether the RGD motif of fibulin-5 affects the binging of 4T1 and MDA-
MB-231 breast cancer cells to different ECM components as well as the αvβ3 integrin. Results 
obtained with MDA-MB-231 cells, which endogenous expression of fibulin-5 is absent or scarcely detected [19], revealed that an intact RGD motif increases the binding of MDA-MB-231 cells particularly to the basal lamina components laminin and type IV collagen, as 
well as to the αvβ3 integrin. In stark contrast, the RGD-to-RGE change drastically reduces this 
binding. Previous reports have involved αvβ3 integrin in breast cancer. Thus, αvβ3 integrin increases metastasis of breast cancer cells to bone [27], therefore it could be a therapeutic target for prevention of skeletal metastasis [28]. Moreover, MDA-MB-231 cells expressing 
fibulin-5 harboring the RGD-to-RGE change do not reduce their ability to invade. Thus, it could be speculated that the RGD motif is a key structural element to promote the antitumor 
effects of fibulin-5, which could be increased by blocking the signaling pathways mediated by 
the activation of integrins that could interact with fibulin-5. These findings would reinforce 
the antitumor effects that intact fibulin-5 can display within the tumor microenvironment.
Conclusion
Our results provide new evidence about the relevance of fibulin-5 in proliferation, 
invasion and the induction of EMT process in 4T1breast cancer cells. Induction of cell 
proliferation and EMT have been also described due to different factors in other commonly 
employed breast cancer cell lines [29, 30]. Our data also highlight the context-specific 
effects associated to fibulin-5 [11, 31]. These findings should help to decipher some of the 
molecular mechanisms underlying the tumor-protecting functions elicited by fibulin-5. Also, 
our findings deepen on the tumor-protective functions that an intact fibulin-5 induces in the 
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tumor microenvironment, which could contribute the development of future therapies for breast cancer treatment.
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